View in EDS HTML Full Text PDF Full Text

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Saved in:
Bibliographic Details
Title: Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Authors: Amgad M; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA., Stovgaard ES; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Balslev E; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Thagaard J; 3DTU Compute, Department of Applied Mathematics, Technical University of Denmark, Lyngby, Denmark.; Visiopharm A/S, Hørsholm, Denmark., Chen W; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Dudgeon S; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Sharma A; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA., Kerner JK; 6PathAI, Cambridge, MA USA., Denkert C; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.; 8Institute of Pathology, Philipps-University Marburg, Marburg, Germany.; German Cancer Consortium (DKTK), Partner Site Charité, Berlin, Germany., Yuan Y; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK., AbdulJabbar K; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Wienert S; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany., Savas P; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Voorwerk L; 14Department of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beck AH; 6PathAI, Cambridge, MA USA., Madabhushi A; 15Case Western Reserve University, Department of Biomedical Engineering, Cleveland, OH USA.; 16Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH USA., Hartman J; 17Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Solna, Sweden., Sebastian MM; 18Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Horlings HM; 19Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hudeček J; 20Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ciompi F; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Moore DA; 22Department of Pathology, UCL Cancer Institute, London, UK., Singh R; 23Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Roblin E; 24Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France., Balancin ML; 25Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., Mathieu MC; 26Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Lennerz JK; 27Department of Pathology, Massachusetts General Hospital, Boston, MA USA., Kirtani P; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India., Chen IC; 29Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Braybrooke JP; 30Nuffield Department of Population Health, University of Oxford, Oxford, UK.; 31Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Pruneri G; 32Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy., Demaria S; 33Weill Cornell Medical College, New York, NY USA., Adams S; 34Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY USA., Schnitt SJ; 35Department of Pathology, Brigham and Women's Hospital, Boston, MA USA., Lakhani SR; 36The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia., Rojo F; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Comerma L; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Badve SS; 39Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN USA., Khojasteh M; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA., Symmans WF; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Sotiriou C; 42Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.; 43ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium., Gonzalez-Ericsson P; 44Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN USA., Pogue-Geile KL; NRG Oncology/NSABP, Pittsburgh, PA USA., Kim RS; NRG Oncology/NSABP, Pittsburgh, PA USA., Rimm DL; 46Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Viale G; 47Department of Pathology, IEO, European Institute of Oncology IRCCS & State University of Milan, Milan, Italy., Hewitt SM; 48Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA., Bartlett JMS; 49Ontario Institute for Cancer Research, Toronto, ON Canada.; 50Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Penault-Llorca F; 51Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France.; 52UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France., Goel S; 53Victorian Comprehensive Cancer Centre building, Peter MacCallum Cancer Centre, Melbourne, Victoria Australia., Lien HC; 54Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Loibl S; 55German Breast Group, c/o GBG-Forschungs GmbH, Neu-Isenburg, Germany., Kos Z; Department of Pathology, BC Cancer, Vancouver, British Columbia Canada., Loi S; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 57Peter MacCallum Cancer Centre, Melbourne, Australia., Hanna MG; 58Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA., Michiels S; 59Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; 60Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France., Kok M; 61Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; 62Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nielsen TO; 63University of British Columbia, Vancouver, British Columbia Canada., Lazar AJ; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 64Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 65Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 66Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Bago-Horvath Z; 67Department of Pathology, Medical University of Vienna, Vienna, Austria., Kooreman LFS; 68GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.; 69Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., van der Laak JAWM; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; 70Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden., Saltz J; 71Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY USA., Gallas BD; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Kurkure U; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA., Barnes M; Roche Diagnostics Information Solutions, Belmont, CA USA., Salgado R; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium., Cooper LAD; 74Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL USA.
Corporate Authors: International Immuno-Oncology Biomarker Working Group
Source: NPJ breast cancer [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 16. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020).
Publication Type: Journal Article; Review
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32411818
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Amgad+M%22">Amgad M</searchLink>; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.<br /><searchLink fieldCode="AU" term="%22Stovgaard+ES%22">Stovgaard ES</searchLink>; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Balslev+E%22">Balslev E</searchLink>; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Thagaard+J%22">Thagaard J</searchLink>; 3DTU Compute, Department of Applied Mathematics, Technical University of Denmark, Lyngby, Denmark.; Visiopharm A/S, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA.<br /><searchLink fieldCode="AU" term="%22Dudgeon+S%22">Dudgeon S</searchLink>; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA.<br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink>; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.<br /><searchLink fieldCode="AU" term="%22Kerner+JK%22">Kerner JK</searchLink>; 6PathAI, Cambridge, MA USA.<br /><searchLink fieldCode="AU" term="%22Denkert+C%22">Denkert C</searchLink>; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.; 8Institute of Pathology, Philipps-University Marburg, Marburg, Germany.; German Cancer Consortium (DKTK), Partner Site Charité, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22AbdulJabbar+K%22">AbdulJabbar K</searchLink>; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Wienert+S%22">Wienert S</searchLink>; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Savas+P%22">Savas P</searchLink>; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Voorwerk+L%22">Voorwerk L</searchLink>; 14Department of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Beck+AH%22">Beck AH</searchLink>; 6PathAI, Cambridge, MA USA.<br /><searchLink fieldCode="AU" term="%22Madabhushi+A%22">Madabhushi A</searchLink>; 15Case Western Reserve University, Department of Biomedical Engineering, Cleveland, OH USA.; 16Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH USA.<br /><searchLink fieldCode="AU" term="%22Hartman+J%22">Hartman J</searchLink>; 17Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Sebastian+MM%22">Sebastian MM</searchLink>; 18Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX USA.<br /><searchLink fieldCode="AU" term="%22Horlings+HM%22">Horlings HM</searchLink>; 19Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hudeček+J%22">Hudeček J</searchLink>; 20Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ciompi+F%22">Ciompi F</searchLink>; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Moore+DA%22">Moore DA</searchLink>; 22Department of Pathology, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; 23Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Roblin+E%22">Roblin E</searchLink>; 24Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Balancin+ML%22">Balancin ML</searchLink>; 25Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Mathieu+MC%22">Mathieu MC</searchLink>; 26Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Lennerz+JK%22">Lennerz JK</searchLink>; 27Department of Pathology, Massachusetts General Hospital, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Kirtani+P%22">Kirtani P</searchLink>; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Chen+IC%22">Chen IC</searchLink>; 29Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Braybrooke+JP%22">Braybrooke JP</searchLink>; 30Nuffield Department of Population Health, University of Oxford, Oxford, UK.; 31Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Pruneri+G%22">Pruneri G</searchLink>; 32Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Demaria+S%22">Demaria S</searchLink>; 33Weill Cornell Medical College, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Adams+S%22">Adams S</searchLink>; 34Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Schnitt+SJ%22">Schnitt SJ</searchLink>; 35Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Lakhani+SR%22">Lakhani SR</searchLink>; 36The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Rojo+F%22">Rojo F</searchLink>; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Comerma+L%22">Comerma L</searchLink>; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Badve+SS%22">Badve SS</searchLink>; 39Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Khojasteh+M%22">Khojasteh M</searchLink>; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.<br /><searchLink fieldCode="AU" term="%22Sotiriou+C%22">Sotiriou C</searchLink>; 42Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.; 43ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Ericsson+P%22">Gonzalez-Ericsson P</searchLink>; 44Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN USA.<br /><searchLink fieldCode="AU" term="%22Pogue-Geile+KL%22">Pogue-Geile KL</searchLink>; NRG Oncology/NSABP, Pittsburgh, PA USA.<br /><searchLink fieldCode="AU" term="%22Kim+RS%22">Kim RS</searchLink>; NRG Oncology/NSABP, Pittsburgh, PA USA.<br /><searchLink fieldCode="AU" term="%22Rimm+DL%22">Rimm DL</searchLink>; 46Department of Pathology, Yale University School of Medicine, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Viale+G%22">Viale G</searchLink>; 47Department of Pathology, IEO, European Institute of Oncology IRCCS & State University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Hewitt+SM%22">Hewitt SM</searchLink>; 48Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA.<br /><searchLink fieldCode="AU" term="%22Bartlett+JMS%22">Bartlett JMS</searchLink>; 49Ontario Institute for Cancer Research, Toronto, ON Canada.; 50Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Penault-Llorca+F%22">Penault-Llorca F</searchLink>; 51Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France.; 52UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Goel+S%22">Goel S</searchLink>; 53Victorian Comprehensive Cancer Centre building, Peter MacCallum Cancer Centre, Melbourne, Victoria Australia.<br /><searchLink fieldCode="AU" term="%22Lien+HC%22">Lien HC</searchLink>; 54Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; 55German Breast Group, c/o GBG-Forschungs GmbH, Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kos+Z%22">Kos Z</searchLink>; Department of Pathology, BC Cancer, Vancouver, British Columbia Canada.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 57Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Hanna+MG%22">Hanna MG</searchLink>; 58Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Michiels+S%22">Michiels S</searchLink>; 59Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; 60Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Kok+M%22">Kok M</searchLink>; 61Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; 62Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nielsen+TO%22">Nielsen TO</searchLink>; 63University of British Columbia, Vancouver, British Columbia Canada.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 64Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 65Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 66Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.<br /><searchLink fieldCode="AU" term="%22Bago-Horvath+Z%22">Bago-Horvath Z</searchLink>; 67Department of Pathology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kooreman+LFS%22">Kooreman LFS</searchLink>; 68GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.; 69Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Laak+JAWM%22">van der Laak JAWM</searchLink>; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; 70Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.<br /><searchLink fieldCode="AU" term="%22Saltz+J%22">Saltz J</searchLink>; 71Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY USA.<br /><searchLink fieldCode="AU" term="%22Gallas+BD%22">Gallas BD</searchLink>; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA.<br /><searchLink fieldCode="AU" term="%22Kurkure+U%22">Kurkure U</searchLink>; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA.<br /><searchLink fieldCode="AU" term="%22Barnes+M%22">Barnes M</searchLink>; Roche Diagnostics Information Solutions, Belmont, CA USA.<br /><searchLink fieldCode="AU" term="%22Salgado+R%22">Salgado R</searchLink>; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Cooper+LAD%22">Cooper LAD</searchLink>; 74Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22International+Immuno-Oncology+Biomarker+Working+Group%22">International Immuno-Oncology Biomarker Working Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 16. <i>Date of Electronic Publication: </i>2020 May 12 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32411818
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-020-0154-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 16
    Titles:
      – TitleFull: Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Amgad M
      – PersonEntity:
          Name:
            NameFull: Stovgaard ES
      – PersonEntity:
          Name:
            NameFull: Balslev E
      – PersonEntity:
          Name:
            NameFull: Thagaard J
      – PersonEntity:
          Name:
            NameFull: Chen W
      – PersonEntity:
          Name:
            NameFull: Dudgeon S
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Kerner JK
      – PersonEntity:
          Name:
            NameFull: Denkert C
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: AbdulJabbar K
      – PersonEntity:
          Name:
            NameFull: Wienert S
      – PersonEntity:
          Name:
            NameFull: Savas P
      – PersonEntity:
          Name:
            NameFull: Voorwerk L
      – PersonEntity:
          Name:
            NameFull: Beck AH
      – PersonEntity:
          Name:
            NameFull: Madabhushi A
      – PersonEntity:
          Name:
            NameFull: Hartman J
      – PersonEntity:
          Name:
            NameFull: Sebastian MM
      – PersonEntity:
          Name:
            NameFull: Horlings HM
      – PersonEntity:
          Name:
            NameFull: Hudeček J
      – PersonEntity:
          Name:
            NameFull: Ciompi F
      – PersonEntity:
          Name:
            NameFull: Moore DA
      – PersonEntity:
          Name:
            NameFull: Singh R
      – PersonEntity:
          Name:
            NameFull: Roblin E
      – PersonEntity:
          Name:
            NameFull: Balancin ML
      – PersonEntity:
          Name:
            NameFull: Mathieu MC
      – PersonEntity:
          Name:
            NameFull: Lennerz JK
      – PersonEntity:
          Name:
            NameFull: Kirtani P
      – PersonEntity:
          Name:
            NameFull: Chen IC
      – PersonEntity:
          Name:
            NameFull: Braybrooke JP
      – PersonEntity:
          Name:
            NameFull: Pruneri G
      – PersonEntity:
          Name:
            NameFull: Demaria S
      – PersonEntity:
          Name:
            NameFull: Adams S
      – PersonEntity:
          Name:
            NameFull: Schnitt SJ
      – PersonEntity:
          Name:
            NameFull: Lakhani SR
      – PersonEntity:
          Name:
            NameFull: Rojo F
      – PersonEntity:
          Name:
            NameFull: Comerma L
      – PersonEntity:
          Name:
            NameFull: Badve SS
      – PersonEntity:
          Name:
            NameFull: Khojasteh M
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Sotiriou C
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Ericsson P
      – PersonEntity:
          Name:
            NameFull: Pogue-Geile KL
      – PersonEntity:
          Name:
            NameFull: Kim RS
      – PersonEntity:
          Name:
            NameFull: Rimm DL
      – PersonEntity:
          Name:
            NameFull: Viale G
      – PersonEntity:
          Name:
            NameFull: Hewitt SM
      – PersonEntity:
          Name:
            NameFull: Bartlett JMS
      – PersonEntity:
          Name:
            NameFull: Penault-Llorca F
      – PersonEntity:
          Name:
            NameFull: Goel S
      – PersonEntity:
          Name:
            NameFull: Lien HC
      – PersonEntity:
          Name:
            NameFull: Loibl S
      – PersonEntity:
          Name:
            NameFull: Kos Z
      – PersonEntity:
          Name:
            NameFull: Loi S
      – PersonEntity:
          Name:
            NameFull: Hanna MG
      – PersonEntity:
          Name:
            NameFull: Michiels S
      – PersonEntity:
          Name:
            NameFull: Kok M
      – PersonEntity:
          Name:
            NameFull: Nielsen TO
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Bago-Horvath Z
      – PersonEntity:
          Name:
            NameFull: Kooreman LFS
      – PersonEntity:
          Name:
            NameFull: van der Laak JAWM
      – PersonEntity:
          Name:
            NameFull: Saltz J
      – PersonEntity:
          Name:
            NameFull: Gallas BD
      – PersonEntity:
          Name:
            NameFull: Kurkure U
      – PersonEntity:
          Name:
            NameFull: Barnes M
      – PersonEntity:
          Name:
            NameFull: Salgado R
      – PersonEntity:
          Name:
            NameFull: Cooper LAD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2020 May 12
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 6
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1